USA CUSTOMERS - SAME PRICE. NO DUTY. NO HIDDEN FEES.

FREE SHIPPING OVER $55

GET 10% OFF FIRST ORDER

Your cart

Your cart is empty

发现Nutridom月见草油的天然益处,它是维护最佳健康的必备伙伴。每粒软胶囊提供500mg优质月见草油,富含Omega-6必需脂肪酸,因支持荷尔蒙平衡、皮肤健康和整体健康而闻名。

产品功效

皮肤健康:月见草油富含γ-亚麻酸(GLA),促进皮肤健康。它有助于维护皮肤屏障功能和水分水平,缓解湿疹、牛皮癣、痤疮和干燥皮肤的症状。

荷尔蒙平衡:月见草油支持荷尔蒙平衡,特别是女性。GLA是前列腺素的前体,调节荷尔蒙水平和月经周期。它帮助减少经前综合症(PMS)和更年期症状,如乳房胀痛、情绪波动和潮热。

抗炎特性:GLA具有天然抗炎特性,有助于减少体内炎症,缓解类风湿关节炎、哮喘和炎症性肠病等炎症性疾病的症状。

神经健康:研究表明,月见草油支持神经健康和功能,特别是在糖尿病神经病变和多发性硬化症等条件下。GLA有助于保护神经细胞并改善神经传导。

心脏健康:GLA具有心血管益处,包括降低血压、改善血管功能和降低胆固醇水平。月见草油支持心脏健康,降低心脏病风险。

头发和指甲健康:月见草油促进健康的头发和指甲。GLA支持毛囊和指甲床的结构和完整性,减少脆性、断裂和分叉。

眼睛健康:GLA是视网膜的组成部分,支持眼睛健康和视力。月见草油帮助减少干眼症状,改善泪液生成。

选择Nutridom月见草油,体验其全面的健康益处,让您的生活焕发新生。

Nutridom 月见草油 500mg,冷压工艺(200粒软胶囊),加拿大制造,高品质,支持女性荷尔蒙平衡,皮肤健康,关节健康,心脏健康和神经系统

Regular price $35.00
Unit price
per 
4.8 (12)

Health Canada Licensed Natural Health Product (NPN 80030725)

自动续订,可跳过或随时取消。

若要添加到购物车,请转至产品页面并选择购买选项
Shipping calculated at checkout.

发现Nutridom月见草油的天然益处,它是维护最佳健康的必备伙伴。每粒软胶囊提供500mg优质月见草油,富含Omega-6必需脂肪酸,因支持荷尔蒙平衡、皮肤健康和整体健康而闻名。

产品功效

皮肤健康:月见草油富含γ-亚麻酸(GLA),促进皮肤健康。它有助于维护皮肤屏障功能和水分水平,缓解湿疹、牛皮癣、痤疮和干燥皮肤的症状。

荷尔蒙平衡:月见草油支持荷尔蒙平衡,特别是女性。GLA是前列腺素的前体,调节荷尔蒙水平和月经周期。它帮助减少经前综合症(PMS)和更年期症状,如乳房胀痛、情绪波动和潮热。

抗炎特性:GLA具有天然抗炎特性,有助于减少体内炎症,缓解类风湿关节炎、哮喘和炎症性肠病等炎症性疾病的症状。

神经健康:研究表明,月见草油支持神经健康和功能,特别是在糖尿病神经病变和多发性硬化症等条件下。GLA有助于保护神经细胞并改善神经传导。

心脏健康:GLA具有心血管益处,包括降低血压、改善血管功能和降低胆固醇水平。月见草油支持心脏健康,降低心脏病风险。

头发和指甲健康:月见草油促进健康的头发和指甲。GLA支持毛囊和指甲床的结构和完整性,减少脆性、断裂和分叉。

眼睛健康:GLA是视网膜的组成部分,支持眼睛健康和视力。月见草油帮助减少干眼症状,改善泪液生成。

选择Nutridom月见草油,体验其全面的健康益处,让您的生活焕发新生。

Supplement Facts

Supplement Facts

Serving Size: 2 to 4 Softgels (Once Daily with a Meal Containing Dietary Fat)

Servings Per Container: 50 to 100 (at 2 to 4 softgels per day)

Ingredient
Amount Per
Serving
% Daily
Value
Evening Primrose Oil (Oenothera biennis, Seed, Cold Pressed)
500 mg
Gamma-Linolenic Acid (GLA, Omega-6)
50 mg
Linoleic Acid (LA, Omega-6)
360 mg

† Daily Value not established

Other Ingredients:
d-alpha Tocopherol (vitamin E)

Clinical Research

Evening primrose oil and borage oil in rheumatologic conditions

American Journal of Clinical Nutrition, 2000

This review examined the clinical evidence for GLA-containing oils including evening primrose oil in inflammatory and rheumatologic conditions, with specific focus on the GLA → DGLA → Prostaglandin E1 pathway. The review established that GLA from evening primrose oil is efficiently converted to DGLA and subsequently to PGE1 a Series 1 prostaglandin with vasodilatory, anti aggregatory, and anti-inflammatory properties. The review confirmed that GLA supplementation from evening primrose oil produces measurable shifts in the prostaglandin balance toward PGE1 and away from pro-inflammatory arachidonic acid metabolites, directly supporting evening primrose oil's mechanism of action for healthy inflammatory response support.

The effect of gamma-linolenic acid on skin barrier function in patients with atopic dermatitis

British Journal of Dermatology, 1989

This randomized, double blind, placebo controlled trial examined the effects of evening primrose oil supplementation on skin barrier function, transepidermal water loss (TEWL), and skin symptoms in patients with atopic dermatitis a condition characterized by impaired skin lipid barrier function and GLA deficiency. The study found that evening primrose oil supplementation significantly improved skin barrier integrity, reduced TEWL, and improved skin hydration and elasticity compared to placebo. The authors attributed the effects to GLA's role in ceramide and phospholipid synthesis in the skin lipid barrier. The findings directly support evening primrose oil's licensed use for skin health and barrier support.

Essential fatty acids and premenstrual syndrome

Journal of Reproductive Medicine, 1983

This foundational review by David Horrobin the leading researcher on GLA and prostaglandin metabolism examined the role of GLA and prostaglandin E1 in premenstrual syndrome (PMS) and hormonal balance. The review established that women with PMS show impaired delta-6-desaturase activity and reduced GLA-to-DGLA conversion, resulting in lower PGE1 production during the luteal phase. Supplementation with evening primrose oil providing GLA directly bypasses this enzymatic impairment and supports PGE1 production, modulating estrogen-sensitive tissue responses and luteal phase signalling. The findings provide the foundational mechanistic basis for evening primrose oil's use for hormonal balance and premenstrual comfort support.

Research information is provided for educational purposes and does not replace the product's approved label information.

Frequently Asked Questions

What is Evening Primrose Oil and what does it do?

Evening Primrose Oil (EPO) is a cold pressed oil extracted from the seeds ofOenothera biennis the evening primrose plant native to North America. It is one of the richest plant sources of gamma-linolenic acid (GLA), a conditionally essential omega-6 fatty acid not widely found in the diet. GLA supports skin barrier function, hormonal balance, and healthy inflammatory response through the GLA → DGLA → Prostaglandin E1 pathway.

What is GLA and why is it important?

Gamma-linolenic acid (GLA) is a conditionally essential omega-6 fatty acid that the body synthesizes from dietary linoleic acid via the delta-6-desaturase enzyme. It is "conditionally essential" because this enzymatic conversion is routinely impaired by aging, chronic stress, insulin resistance, alcohol consumption, and hormonal fluctuations meaning many adults cannot produce adequate GLA from diet alone even with sufficient linoleic acid intake. GLA is the precursor to dihomo-gamma linolenic acid (DGLA) and prostaglandin E1 (PGE1) a Series 1 prostaglandin that supports healthy inflammatory balance, skin barrier integrity, and hormonal signalling. Evening primrose oil delivers GLA directly, bypassing the delta-6-desaturase enzymatic step entirely.

How does Evening Primrose Oil support skin health?

GLA is incorporated into ceramides and phospholipids that form the skin lipid barrier the lamellar structure between corneocytes that governs transepidermal water loss (TEWL) and barrier integrity. GLA deficiency is associated with increased TEWL, dry skin, reduced elasticity, and impaired barrier function. Evening primrose oil supplementation supports ceramide synthesis and barrier repair, improving skin hydration and elasticity from within. The skin barrier benefit of GLA is distinct from topical moisturizers it works by restoring the structural lipid composition of the barrier at the cellular level through oral supplementation.

How does Evening Primrose Oil support hormonal balance and menstrual health?

DGLA the elongation product of GLA is a precursor to prostaglandin E1 (PGE1) and to 15-HETrE, both of which modulate estrogen sensitive tissue responses and luteal phase signalling. This prostaglandin pathway is the mechanism through which evening primrose oil supports premenstrual comfort, cyclical breast tenderness, and menstrual cycle regularity. GLA's conversion to PGE1 rather than to pro inflammatory arachidonic acid metabolites supports a more balanced prostaglandin profile during the luteal phase the period most associated with premenstrual symptoms.

Why is cold pressed extraction important for Evening Primrose Oil?

Cold pressing uses mechanical pressure at controlled low temperatures, preserving the full fatty acid profile including heat sensitive GLA and linoleic acid. Solvent extraction using hexane at elevated temperatures degrades polyunsaturated fatty acids, destroys native tocopherols (Vitamin E), and may leave trace solvent residues in the finished oil. Cold pressed EPO retains its complete fatty acid composition, natural antioxidant content, and guaranteed GLA potency.

Who should not take Evening Primrose Oil?

Do not use if you have a seizure disorder or are taking phenothiazine medications GLA may lower the seizure threshold in susceptible individuals when combined with phenothiazines. Consult a healthcare practitioner before use if you are pregnant or breastfeeding. Consult a healthcare practitioner before use if you are taking blood-thinning medications such as warfarin GLA's conversion to PGE1 has anti-aggregatory properties that may interact with anticoagulant therapy.